Search AMIA.org

Building upon our previous work on predicting treatment retention in medications for opioid use disorder, we aimed to improve 6-month retention prediction in buprenorphine-naloxone (BUP-NAL) therapy by incorporating features derived from large language models (LLMs) applied to unstructured clinical notes.

The objective of this study is to evaluate retrieval-augmented prediction for forecasting hospital length of stay (LOS) following surgery compared to traditional machine learning (ML), standalone large language models (LLMs), and retrieval-augmented generation (RAG) approaches.

Externalizing behaviors in children, such as aggression, hyperactivity, and defiance, are influenced by complex interplays between genetic predispositions and environmental factors, particularly parental behaviors. Unraveling these intricate causal relationships can benefit from the use of robust data-driven methods.

To identify a brief scale to accurately assess digital skills among older adults for use in identifying need for support to use digital health tools.

This work highlights successes and challenges of implementing a novel responsible artificial intelligence (RAI) framework, emphasizing healthcare disciplines needed to operationalize it.

Neurofibromatosis type 1 (NF1) is a rare genetic disorder affecting multiple organ systems with significant clinical heterogeneity. Managing individuals with NF1 is challenging due to variability in disease progression and outcomes and limited early risk assessment tools.

Effective communication is crucial in healthcare, and for patients with a non-English language preference (NELP), professional interpreters are recognized as the gold standard in supporting bidirectional communication. However, interpreters are not always readily available, prompting the exploration of other options for translation and interpretation. The recent developments in artificial intelligence-based neural network translation tools, namely neural machine translation (NMT) may enable robust interpretation and translation.

Immunotherapy has emerged as a promising treatment for advanced non-small cell lung cancer (NSCLC), but accurately predicting which patients will benefit from it remains a major clinical challenge. To address this, we aim to develop a novel multimodal method, DeepAFM, that integrates histopathology, genomic features, and clinical information to predict patient responses to anti-PD-(L)1 immunotherapy.

Electronic Health Records (EHRs) sampled from different populations can introduce unwanted biases, limit individual-level data sharing, and make the data and fitted model hardly transferable across different population groups. In this context, our main goal is to design an effective method to transfer knowledge between population groups, with computable guarantees for suitability, and that can be applied to quantify treatment disparities.

By October 1, 2024, over 450,000 COVID-19 manuscripts were published, with 10% posted as unreviewed preprints. While they accelerate knowledge sharing, their inconsistent quality complicates systematic studies.